Up to 10% of Early-Onset Metastatic Colorectal Cancer Cases May Be Driven by Undiagnosed IBD
As many as 10% of early-onset metastatic colorectal cancer cases may be attributable to undiagnosed inflammatory bowel disease, a study suggests.
Diagnosis & Disease Information
Standing Orders for Primary Prophylaxis Colony-Stimulating Factor to Improve Guideline Adherence
Researchers sought to determine if automated standing orders for prophylaxis colony-stimulating factor would improve adherence to clinical guidelines for use according to risk for febrile neutropenia.
Physical Exercise During Chemotherapy Feasible, Associated With Favorable Outcomes
Researchers sought to determine whether initiating exercise during chemotherapy was superior to initiation after chemotherapy.
Patients With CRC Often Delay Seeking Medical Care After Symptom Onset
Researchers in Turkey explored why patients with CRC tended to delay seeking medical care after initial symptom onset.
Patients With CRC Often Delay Seeking Medical Care After Symptom Onset
Researchers in Turkey explored why patients with CRC tended to delay seeking medical care after initial symptom onset.
Use of Life Expectancy as a Criterion to Discontinue Cancer Screenings
A survey study sought to examine physician attitudes about using a life expectancy of less than 10 years as a criterion for discontinuing cancer screening.
Trial Raises Questions About Effectiveness of Colonoscopy for Colorectal Cancer Screening
Screening colonoscopy may provide a small reduction in the risk of colorectal cancer and no reduction in the risk of death, a study suggests.
Data Reveal Growing Burden of Metastatic Cancers in the US
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
A Banana a Day May Keep Upper GI Cancers Away
For patients with Lynch disease, taking a daily supplement containing resistant starch reduced upper gastrointestinal cancers by more than half.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...